Trevi Therapeutics Aktie - TRVI

Professionelle Tools für Privatanleger.

Premium

Current Price

4,52

Gebot

4,10

Fragen

4,67

Volumen

574.871

4,32 Tagesbereich 4,68

1,27 52-Wochen-Bereich 4,675

Marktkapitalisierung

347,433M

Handelsende

4,36

Handelsbeginn

4,38

Letzte Trade

4.42

Letzter Handelszeitpunkt

Finanzvolumen

US$ 2.606.719

VWAP

4,5344

Durchschnittliches Volumen (3 Mio.)

1.841.605

Ausgegebene Aktien

76.865.711

Dividendenrendite

Kurs-Gewinn-Verhältnis

-12,14

Gewinn pro Aktie (EPS)

-0,38

Erlöse

Nettogewinn

-29,07M

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with... Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, or IPF, and levodopa-induced dyskinesia, or LID, in patients with Parkinson's disease. Mehr anzeigen

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.trevitherapeutics.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Trevi Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TRVI. The last closing price for Trevi Therapeutics was US$4,36. Over the last year, Trevi Therapeutics shares have traded in a share price range of US$ 1,27 to US$ 4,675.

Trevi Therapeutics currently has 76.865.711 shares in issue. The market capitalisation of Trevi Therapeutics is US$335,13 million. Trevi Therapeutics has a price to earnings ratio (PE ratio) of -12.14.

FNB Harvest annonce les distributions annuelles finales réinvesties pour 2024

Groupe de portefeuilles Harvest Inc. (« Harvest ») annonce les distributions finales réinvesties annuelles pour les FNB Harvest pour l'année d'imposition 2024. Veuillez noter que les...

FNB Harvest annonce Distributions réinvesties annuelles estimées révisées pour 2024

Groupe de portefeuilles Harvest Inc. (« Harvest ») annonce les distributions réinvesties annuelles estimées pour les FNB Harvest pour l'année d'imposition 2024. Veuillez noter que les...

FNB Harvest annonce les distributions de décembre 2024

Groupe de portefeuilles Harvest Inc. (« Harvest ») annonce les distributions suivantes pour les FNB Harvest pour le mois se terminant le 31 décembre 2024. La distribution sera versée le ou vers...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Trevi Therapeutics Announces Pricing of $50 Million Underwritten Offering

Trevi Therapeutics Announces Pricing of $50 Million Underwritten Offering PR Newswire NEW HAVEN, Conn., Dec. 16, 2024 NEW HAVEN, Conn., Dec. 16, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc...

Form 8-K - Current report

Trevi Therapeutics Announces Positive Outcome from Sample Size Re-estimation Resulting in No Change to the Current Sample Size for the Phase 2b CORAL Trial in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough

Trevi Therapeutics Announces Positive Outcome from Sample Size Re-estimation Resulting in No Change to the Current Sample Size for the Phase 2b CORAL Trial in Idiopathic Pulmonary Fibrosis...

Form 8-K - Current report

Trevi Therapeutics Announces Positive Topline Results from Human Abuse Potential Study of Oral Nalbuphine

Trevi Therapeutics Announces Positive Topline Results from Human Abuse Potential Study of Oral Nalbuphine PR Newswire NEW HAVEN, Conn., Dec. 3, 2024 Statistically significant lower "Drug Liking...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.305	7.23606168446	4.215	4.59	3.96	753454	4.26017995	CS
4	1.91	73.1800766284	2.61	4.675	2.36	4608603	3.71368104	CS
12	1.51	50.1661129568	3.01	4.675	2.36	1841605	3.56385081	CS
26	1.82	67.4074074074	2.7	4.675	2.36	967043	3.49561163	CS
52	3.23	250.387596899	1.29	4.675	1.27	616120	3.32619223	CS
156	3.7378	477.857325492	0.7822	4.6834	0.46	537317	2.66095385	CS
260	0.78	20.8556149733	3.74	8.5	0.46	372372	2.60964161	CS

TRVI - Frequently Asked Questions (FAQ)

What is the current Trevi Therapeutics share price?

The current share price of Trevi Therapeutics is US$ 4,52

How many Trevi Therapeutics shares are in issue?

Trevi Therapeutics has 76.865.711 shares in issue

What is the market cap of Trevi Therapeutics?

The market capitalisation of Trevi Therapeutics is USD 335,13M

What is the 1 year trading range for Trevi Therapeutics share price?

Trevi Therapeutics has traded in the range of US$ 1,27 to US$ 4,675 during the past year

What is the PE ratio of Trevi Therapeutics?

The price to earnings ratio of Trevi Therapeutics is -12,14

What is the reporting currency for Trevi Therapeutics?

Trevi Therapeutics reports financial results in USD

What is the latest annual profit for Trevi Therapeutics?

The latest annual profit of Trevi Therapeutics is USD -29,07M

What is the registered address of Trevi Therapeutics?

The registered address for Trevi Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Trevi Therapeutics website address?

The website address for Trevi Therapeutics is www.trevitherapeutics.com

Which industry sector does Trevi Therapeutics operate in?

Trevi Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
FCUVFocus Universal Inc	US$ 0,9499 (174,93%)	260,93M
NITON2OFF Inc	US$ 2,6306 (145,85%)	358,28M
CRNCCerence Inc	US$ 19,33 (143,76%)	161,8M
KITTNauticus Robotics Inc	US$ 3,8249 (140,56%)	104,8M
ACONAclarion Inc	US$ 0,2984 (110,14%)	305,64M
HWHHWH International Inc	US$ 0,4621 (-28,80%)	7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF	US$ 5,69 (-26,30%)	24,77M
RAINRain Enhancement Technologies Holdco Inc	US$ 5,59 (-23,42%)	161,15k
PTLEPTL Ltd	US$ 9,35 (-23,30%)	1,04M
NXUNXU Inc	US$ 0,725868 (-22,78%)	7,59M
NITON2OFF Inc	US$ 2,6306 (145,85%)	350,92M
TGLTreasure Global Inc	US$ 0,382 (101,58%)	330,82M
ACONAclarion Inc	US$ 0,2984 (110,14%)	305,59M
FCUVFocus Universal Inc	US$ 0,9499 (174,93%)	259,78M
NVDANVIDIA Corporation	US$ 144,47 (4,45%)	222,72M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Trevi Therapeutics Inc (TRVI) Börsenkurse

Trevi Therapeutics Inc (TRVI)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Trevi Therapeutics Inc

TRVI Neueste Nachrichten

TRVI - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen